{"id":17492,"date":"2026-09-03T12:31:26","date_gmt":"2026-09-03T04:31:26","guid":{"rendered":"https:\/\/fotonmedix.com\/?p=17492"},"modified":"2026-09-03T12:31:26","modified_gmt":"2026-09-03T04:31:26","slug":"deep-tissue-photobiomodulation-resolves-canine-hip-dysplasia","status":"publish","type":"post","link":"https:\/\/fotonmedix.com\/ar\/deep-tissue-photobiomodulation-resolves-canine-hip-dysplasia.html\/","title":{"rendered":"\u0627\u0644\u062a\u0639\u062f\u064a\u0644 \u0627\u0644\u062d\u064a\u0648\u064a \u0627\u0644\u0636\u0648\u0626\u064a \u0644\u0644\u0623\u0646\u0633\u062c\u0629 \u0627\u0644\u0639\u0645\u064a\u0642\u0629 \u064a\u0639\u0627\u0644\u062c \u062e\u0644\u0644 \u0627\u0644\u062a\u0646\u0633\u062c \u0627\u0644\u0648\u0631\u0643\u064a \u0644\u062f\u0649 \u0627\u0644\u0643\u0644\u0627\u0628"},"content":{"rendered":"

High-peak multi-wavelength delivery ensures rapid deep-capsule photon saturation, optimizes hemoglobin and water chromophore absorption curves, and eliminates thermal buildup via dynamic pulse gating.<\/p>\n\n\n\n

Veterinarians treating canine degenerative joint disease consistently hit the same wall during physical rehabilitation sessions. An eight-year-old German Shepherd enters the clinic exhibiting severe Grade III bilateral hip dysplasia. The dog winces during passive range of motion assessments, refuses weight-bearing on the left pelvic limb, and displays muscle atrophy throughout the gluteal group. Oral non-steroidal anti-inflammatory drugs have triggered elevated liver enzymes, while standard joint supplements yield negligible functional improvement. Technicians struggle to deliver adequate energy to articular cartilage buried beneath five centimeters of dense muscle and fibrous fascia without overheating the dermal surface. Low-power units fail to penetrate these structures, simply scattering light across the skin and burning clinic schedule time with ineffective treatment courses.<\/p>\n\n\n\n

The Biophysical Reality of Deep Target Energy Penetration<\/h2>\n\n\n\n

Treating canine joint disease demands an understanding of photon transport through stratified biological tissue. When attempting to treat osteoarthritis within the acetabulofemoral joint of a large canine, photons face immediate optical attenuation. The dermal layer, rich in melanin, along with dense subcutaneous adipose tissue, rapidly scatters and absorbs standard light emissions before target structures receive adequate fluence.<\/p>\n\n\n\n

Photons traversing biological tissue encounter two dominant phenomena: Rayleigh and Mie scattering, alongside target absorption. In dense canine muscle layers, scattering accounts for over ninety percent of beam attenuation when utilizing superficial energy sources. To overcome this barrier, energy delivery must balance target chromophore specificity with minimal optical scattering.<\/p>\n\n\n\n

Standard Class III units, delivering less than half a watt, cannot overcome tissue scatter coefficients to deposit measurable therapeutic thresholds into deep joint capsules. Photobiomodulation operates on the Arndt-Schulz rule of biphasic dose response. Delivering too few photons induces zero cellular change; delivering too many causes photothermal necrosis. Achieving the therapeutic window between four to eight Joules per square centimeter at the target articular cartilage requires high-irradiance delivery at the skin surface.<\/p>\n\n\n\n

When high-fluence Class IV energy reaches chondrocytes and synovial fibroblasts, cytochrome c oxidase within the mitochondrial respiratory chain absorbs the incoming photons. This triggers immediate dissociation of inhibitory nitric oxide from cytochrome c oxidase unit IV. As a direct consequence, electron transport accelerates, increasing proton gradients across the mitochondrial inner membrane. The resulting upregulation of adenosine triphosphate synthesis fuels cellular repair pathways, while secondary messenger cascades downregulate pro-inflammatory cytokines, specifically tumor necrosis factor-alpha and interleukin-one beta.<\/p>\n\n\n\n

Dual Chromophore Dynamics: 980nm Hemoglobin and 1470nm Water Targeting<\/h2>\n\n\n\n

Clinical efficacy hinges on optical absorption matching tissue composition. Cartilage degradation and chronic synovial inflammation involve both hyperemic microvascular structures and water-dense proteoglycan matrices. Monochromatic therapy routinely fails because complex pathology involves distinct chromophores at varying tissue depths.<\/p>\n\n\n\n

The 980nm wavelength demonstrates high absorption in deoxygenated and oxygenated hemoglobin, coupled with moderate water absorption. In chronically inflamed canine joints, microvascular stasis limits nutrient exchange and traps metabolic waste within periarticular tissues. Irradiating the region with 980nm energy induces localized photothermal vasodilation, clearing extravasated fluids and driving oxygen delivery into hypoxic joint margins. This stimulation of microcirculation accelerates macrophage phenotypic switching from pro-inflammatory M1 states to regenerative M2 phenotypes.<\/p>\n\n\n\n

Conversely, the 1470nm wavelength interacts directly with interstitial and intracellular water molecules. Its absorption coefficient in water exceeds that of 980nm and 810nm spectra by significant orders of magnitude. Canine articular cartilage consists of sixty-five to eighty percent water bound within a collagen and proteoglycan meshwork. Applying 1470nm photon emissions targets this aqueous component, stimulating localized interstitial thermal expansion that modifies cell membrane permeability without triggering bulk thermal tissue ablation.<\/p>\n\n\n\n

Combining 980nm and 1470nm simultaneously creates a synergistic interaction across extracellular tissue architecture. The 980nm wavelength addresses vascular perfusion and mitochondrial metabolic recovery, while 1470nm selectively modulates water-dense inflammatory edemas and synovial effusions. Utilizing an advanced veterinary laser therapy machine capable of modulating both wavelengths ensures that neither vascular stasis nor tissue fluid saturation impedes therapeutic photon transit to the target subchondral bone.<\/p>\n\n\n\n

Thermal Relaxation Time and Duty Cycle Management<\/h2>\n\n\n\n

Delivering therapeutic photon densities through thick canine tissue risks thermal discomfort or skin injury if administered continuously. Surface melanophores and hemoglobin quickly absorb high-density photons, converting radiant energy into heat. Without strategic temporal modulation, surface temperatures rapidly approach the forty-three degrees Celsius threshold where structural proteins begin denaturing.<\/p>\n\n\n\n

Overcoming this photothermal bottleneck requires leveraging the thermal relaxation time of canine dermal tissues. Thermal relaxation time represents the duration required for a targeted biological structure to lose fifty percent of its accumulated heat through thermal diffusion. Canine dermis and epidermis possess thermal relaxation constants in the millisecond domain. When energy is applied continuously, tissue accumulation outpaces heat dissipation, causing rapid thermal spikes.<\/p>\n\n\n\n

Implementing a pulsed duty cycle breaks continuous photon delivery into discrete, high-irradiance pulses separated by thermal recovery intervals. Operating at duty cycles between twenty to fifty percent allows peak power bursts to project deep into the acetabulum while intervening quiet phases allow superficial cutaneous tissues to cool.<\/p>\n\n\n\n

Frequency modulation directly affects cellular stimulation:<\/p>\n\n\n\n

Low repetition rates between ten and one hundred Hertz downregulate peripheral sensory nerve conduction velocity, providing immediate relief from neuropathic and articular pain.<\/p>\n\n\n\n

Medium frequencies between five hundred and two thousand Hertz stimulate localized lymphatic drainage pathways, resolving persistent joint effusions.<\/p>\n\n\n\n

High frequencies reaching five to ten thousand Hertz maximize mitochondrial enzymatic uptake within chondrocytes, supporting structural matrix synthesis.<\/p>\n\n\n\n

Deploying high peak irradiance through controlled duty cycles enables the best laser therapy device for dogs to flood deep degenerative hip pathology with therapeutic dosages without provoking cutaneous discomfort or canine agitation.<\/p>\n\n\n\n

\u0645\u0642\u0627\u0631\u0646\u0629 \u0628\u064a\u0646 \u0627\u0644\u0628\u0646\u0649 \u0627\u0644\u0647\u0646\u062f\u0633\u064a\u0629 \u0639\u0628\u0631 \u0627\u0644\u0645\u0646\u0635\u0627\u062a \u0627\u0644\u0628\u064a\u0637\u0631\u064a\u0629 \u0645\u0646 \u0627\u0644\u0641\u0626\u0629 \u0627\u0644\u0631\u0627\u0628\u0639\u0629<\/h2>\n\n\n\n

Clinical outcomes depend directly on hardware capability. Handheld low-power devices, consumer mats, and basic surgical systems fail to provide the balance of penetration, thermal safety, and power output needed for large-animal joint disorders. Investing in reliable veterinary laser therapy equipment requires examining technical capabilities side by side.<\/p>\n\n\n\n

\u0645\u0639\u0644\u0645\u0629 \u0627\u0644\u062a\u0634\u063a\u064a\u0644<\/strong><\/td>Class IIIb Low-Level Units<\/strong><\/td>Monochromatic Class IV Units<\/strong><\/td>High-Peak Dual-Wavelength Class IV Units<\/strong><\/td><\/tr><\/thead>
\u0642\u0648\u0629 \u0627\u0644\u062e\u0631\u062c \u0627\u0644\u0642\u0635\u0648\u0649<\/td>0.1W \u2013 0.5W<\/td>10 \u0648\u0627\u062a \u2013 15 \u0648\u0627\u062a \u0628\u0634\u0643\u0644 \u0645\u0633\u062a\u0645\u0631<\/td>15W \u2013 30W Superpulsed \/ Gated<\/td><\/tr>
Available Emission Wavelengths<\/td>650nm \/ 808nm<\/td>810nm or 980nm Single<\/td>980nm + 1470nm Dual Combination<\/td><\/tr>
Dermal Penetration Depth<\/td>5mm to 15mm<\/td>30mm to 45mm<\/td>Up to 80mm in Dense Musculature<\/td><\/tr>
Thermal Risk Profile<\/td>Negligible (Zero tissue warming)<\/td>High under static application<\/td>Controlled via duty cycle modulation<\/td><\/tr>
Target Pathology Application<\/td>Superficial wounds, small ears<\/td>Superficial muscle strains<\/td>Deep degenerative joint diseases, hip dysplasia<\/td><\/tr>
Session Duration for Large Joint<\/td>30 to 45 minutes<\/td>12 to 18 minutes<\/td>4 to 8 minutes per articulation<\/td><\/tr>
Chromophore Selectivity<\/td>\u0623\u0648\u0643\u0633\u064a\u062f\u064a\u0632 \u0627\u0644\u0633\u064a\u062a\u0648\u0643\u0631\u0648\u0645 \u0633\u064a \u0641\u0642\u0637<\/td>\u0625\u0646\u0632\u064a\u0645 \u0623\u0648\u0643\u0633\u064a\u062f\u064a\u0632 \u0627\u0644\u0633\u064a\u062a\u0648\u0643\u0631\u0648\u0645 \u0633\u064a \u0623\u0648 \u0627\u0644\u0647\u064a\u0645\u0648\u062c\u0644\u0648\u0628\u064a\u0646<\/td>Cytochrome c oxidase, Hemoglobin, and Water<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Equipping a practice with veterinary laser therapy equipment that pairs 980nm microvascular stimulation with 1470nm interstitial fluid targeting reduces treatment times while ensuring adequate photon density reaches deep degenerative tissues.<\/p>\n\n\n

\n
\"Laser<\/figure>\n<\/div>\n\n\n

\u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644 \u0627\u0644\u062d\u0627\u0644\u0629 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0627\u0644\u0645\u0648\u062b\u0642\u0629<\/h2>\n\n\n\n

The following case protocol illustrates deep-capsule photobiomodulation in a clinical veterinary orthopedic setting.<\/p>\n\n\n\n

Case File Reference: VET-ORTHO-2026-8842<\/p>\n\n\n\n

Subject: Canine, German Shepherd Dog, Castrated Male<\/p>\n\n\n\n

Age: 8 Years 4 Months<\/p>\n\n\n\n

Weight: 41.2 kg<\/p>\n\n\n\n

Confirmed Diagnosis: Bilateral Coxofemoral Osteoarthritis secondary to Severe Grade III Canine Hip Dysplasia. Moderate secondary periarticular osteophytosis along the dorsal acetabular rim and femoral neck, confirmed via orthogonal pelvic radiographs under sedation.<\/p>\n\n\n\n

Prior Therapy: Carprofen administered at 4.4 mg\/kg daily for five months; discontinued due to persistent gastrointestinal irritation and elevated alanine aminotransferase. Adjunctive glucosamine and chondroitin provided minimal functional improvement.<\/p>\n\n\n\n

Clinical Presentation: Bilateral pelvic limb lameness, score 4\/5 on the modified Glasgow visual analog scale. Persistent weight shifting toward thoracic limbs. Pronounced bilateral gluteal and quadriceps muscle atrophy, measured via thigh circumference gauge (Right: 38.2 cm, Left: 37.5 cm). Pain vocalization upon hip extension beyond sixty degrees.<\/p>\n\n\n\n

\u0628\u0631\u0648\u062a\u0648\u0643\u0648\u0644 \u0627\u0644\u0639\u0644\u0627\u062c \u0627\u0644\u0633\u0631\u064a\u0631\u064a \u0627\u0644\u0643\u0627\u0645\u0644<\/h3>\n\n\n\n
\u0641\u0647\u0631\u0633 \u0627\u0644\u062c\u0644\u0633\u0627\u062a<\/strong><\/td>\u0627\u0644\u062c\u062f\u0648\u0644 \u0627\u0644\u0632\u0645\u0646\u064a \u0627\u0644\u0645\u0646\u0642\u0636\u064a<\/strong><\/td>\u0646\u0633\u0628\u0629 \u0627\u0644\u0637\u0648\u0644 \u0627\u0644\u0645\u0648\u062c\u064a (980 \u0646\u0627\u0646\u0648\u0645\u062a\u0631 \/ 1470 \u0646\u0627\u0646\u0648\u0645\u062a\u0631)<\/strong><\/td>\u0645\u062a\u0648\u0633\u0637 \u0627\u0644\u0637\u0627\u0642\u0629 (\u0648\u0627\u0637)<\/strong><\/td>\u062a\u0631\u062f\u062f \u0627\u0644\u0646\u0628\u0636 \u0648\u062f\u0648\u0631\u0629 \u0627\u0644\u062a\u0634\u063a\u064a\u0644<\/strong><\/td>\u0625\u062c\u0645\u0627\u0644\u064a \u0627\u0644\u0637\u0627\u0642\u0629 \u0627\u0644\u0645\u064f\u0642\u062f\u064e\u0651\u0645\u0629 (\u062c\u0648\u0644)<\/strong><\/td>Fluence at Skin Surface (J\/cm\u00b2)<\/strong><\/td>\u0627\u0644\u0645\u0644\u0627\u062d\u0638\u0627\u062a \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0648\u0627\u0644\u0645\u0639\u0627\u0644\u0645 \u0627\u0644\u0645\u064a\u0643\u0627\u0646\u064a\u0643\u064a\u0629 \u0627\u0644\u062d\u064a\u0648\u064a\u0629<\/strong><\/td><\/tr><\/thead>
\u0627\u0644\u062c\u0644\u0633\u0629 1<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u0623\u0648\u0644<\/td>70% \/ 30%<\/td>12.0 \u0648\u0627\u0637<\/td>50 Hz, 30% Duty Cycle<\/td>3,600 J per joint<\/td>18 \u062c\u0648\u0644\/\u0633\u0645\u00b2<\/td>High initial muscle guarding; patient tolerated slow overlapping circular sweeping over gluteal muscle mass.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 2<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u062b\u0627\u0644\u062b<\/td>70% \/ 30%<\/td>14.0 W<\/td>50 Hz, 35% Duty Cycle<\/td>4,200 J per joint<\/td>21 J\/cm\u00b2<\/td>Mild post-treatment myofascial relaxation noted; reduced hip extension resistance noted during exam.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 3<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u0633\u0627\u062f\u0633<\/td>60% \/ 40%<\/td>15.0 \u0648\u0627\u0637<\/td>100 Hz, 40% Duty Cycle<\/td>4,800 J per joint<\/td>24 J\/cm\u00b2<\/td>Weight-bearing distribution during static stance improved; stance analysis shows less forward load-shifting.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 4<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u062a\u0627\u0633\u0639<\/td>60% \/ 40%<\/td>16.0 W<\/td>250 Hz, 40% Duty Cycle<\/td>5,200 J per joint<\/td>26 J\/cm\u00b2<\/td>Owner reports patient rises from hardwood floors without slipping; eliminated morning stiffness.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 5<\/td>Day 13<\/td>50% \/ 50%<\/td>18.0 \u0648\u0627\u0637<\/td>500 Hz, 45% Duty Cycle<\/td>6,000 J per joint<\/td>30 J\/cm\u00b2<\/td>Passive hip extension increased by eighteen degrees bilateral without pain vocalization or muscle tremor.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 6<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u0633\u0627\u0628\u0639 \u0639\u0634\u0631<\/td>50% \/ 50%<\/td>18.0 \u0648\u0627\u0637<\/td>1,000 Hz, 50% Duty Cycle<\/td>6,400 J per joint<\/td>32 J\/cm\u00b2<\/td>Significant reduction in crepitus; patient initiating trot during outdoor relief walks without limping.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 \u0627\u0644\u0633\u0627\u0628\u0639\u0629<\/td>Day 22<\/td>40% \/ 60%<\/td>20.0 W<\/td>2,500 Hz, 50% Duty Cycle<\/td>7,200 J per joint<\/td>36 J\/cm\u00b2<\/td>Thigh circumference measured at 39.8 cm right and 39.4 cm left, reflecting active muscle mass recovery.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 8<\/td>\u0627\u0644\u064a\u0648\u0645 \u0627\u0644\u062b\u0627\u0645\u0646 \u0648\u0627\u0644\u0639\u0634\u0631\u0648\u0646<\/td>40% \/ 60%<\/td>20.0 W<\/td>5,000 Hz, 50% Duty Cycle<\/td>7,200 J per joint<\/td>36 J\/cm\u00b2<\/td>Patient clears ten-centimeter obstacle course hurdles in physical rehab; gait symmetry score normalized to 94%.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 9<\/td>Day 38<\/td>50% \/ 50%<\/td>18.0 \u0648\u0627\u0637<\/td>1,000 Hz, 40% Duty Cycle<\/td>5,400 J per joint<\/td>27 J\/cm\u00b2<\/td>Maintenance phase entry. Owner reports full engagement in daily thirty-minute leash walks on natural terrain.<\/td><\/tr>
\u0627\u0644\u062c\u0644\u0633\u0629 10<\/td>Day 52<\/td>50% \/ 50%<\/td>16.0 W<\/td>500 Hz, 35% Duty Cycle<\/td>4,800 J per joint<\/td>24 J\/cm\u00b2<\/td>Full clinical remission of lameness. Liver enzyme values returned to baseline following sustained non-pharmacological care.<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n

Photobiomodulation was administered using a large non-contact divergent therapy handpiece held perpendicular to the skin surface, systematically moving across the greater trochanter, cranial acetabular rim, ischial tuberosity, and adjacent lumbosacral junction. The total treatment zone covered approximately two hundred square centimeters per pelvic quadrant.<\/p>\n\n\n\n

Clinical Outcomes and Practical Practice Integration<\/h2>\n\n\n\n

Relying solely on pharmaceutical pain management in canine orthopedic cases presents significant therapeutic risks. Non-steroidal anti-inflammatory medications suppress prostaglandin synthesis downstream, masking clinical pain without addressing joint degeneration. Over extended periods, chronic non-steroidal therapy risks renal compromise, gastric ulceration, and hepatic strain, particularly in aging canines whose organ reserve is already reduced. When pharmaceutical therapies are discontinued due to organ toxicity, practitioners face limited options beyond surgical salvage procedures like femoral head ostectomy or total hip replacement, which carry high financial costs and lengthy recovery periods.<\/p>\n\n\n\n

Deep-penetrating Class IV multi-wavelength laser therapy provides a targeted non-pharmacological solution. High-output photon delivery shifts joint metabolism by stimulating ATP synthesis and dampening synovial inflammation directly within subchondral and periarticular tissues. Combining 980nm microvascular stimulation with 1470nm water chromophore targeting addresses both vascular congestion and joint effusion.<\/p>\n\n\n\n

Integrating a veterinary laser therapy machine into everyday clinical workflows transforms practice economics and patient quality of life. Rehabilitation sessions drop from drawn-out low-power procedures to targeted ten-minute treatments. Canines experience rapid functional recovery without systemic drug burdens, and owners observe marked mobility improvements within the first four sessions. Practices that adopt modern veterinary laser therapy equipment bridge the gap between conservative medical management and invasive surgery, establishing a reliable, evidence-based standard for lifelong canine joint care.<\/p>","protected":false},"excerpt":{"rendered":"

High-peak multi-wavelength delivery ensures rapid deep-capsule photon saturation, optimizes hemoglobin and water chromophore absorption curves, and eliminates thermal buildup via dynamic pulse gating. Veterinarians treating canine degenerative joint disease consistently hit the same wall during physical rehabilitation sessions. An eight-year-old German Shepherd enters the clinic exhibiting severe Grade III bilateral hip dysplasia. The dog winces […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"themepark_post_bcolor":"#f5f5f5","themepark_post_width":"1022px","themepark_post_img":"","themepark_post_img_po":"left","themepark_post_img_re":false,"themepark_post_img_cover":false,"themepark_post_img_fixed":false,"themepark_post_hide_title":false,"themepark_post_main_b":"","themepark_post_main_p":100,"themepark_paddingblock":false,"slim_seo":{"title":"Canine Hip Dysplasia Deep Laser Therapy Solutions","description":"Resolve deep canine hip dysplasia pain using dual-wavelength Class IV laser therapy targeting hemoglobin and water chromophores without tissue overheating."},"_geo_short_summary":"","_geo_structured_desc":"","_geo_faqs":"","_geo_key_points":"","_geo_target_audience":"","_geo_content_type":"","_geo_last_modified":"","_geo_version":0,"themepark_seo_title":"","themepark_seo_description":"","_slim_seo_primary_term_category":0,"_slim_seo_primary_term_post_tag":0,"footnotes":""},"categories":[19],"tags":[815,816,840],"class_list":["post-17492","post","type-post","status-publish","format-standard","hentry","category-industry-news","tag-laser-therapy-machine","tag-laser-therapy-device","tag-veterinary-laser-therapy"],"metadata":{"_edit_lock":["1788404316:1"],"wpil_sync_report3":["1"],"_edit_last":["1"],"_aioseo_title":[null],"_aioseo_description":[null],"_aioseo_og_title":[""],"_aioseo_og_description":[""],"_aioseo_og_article_section":[""],"_aioseo_twitter_title":[""],"_aioseo_twitter_description":[""],"_aioseo_keywords":["a:0:{}"],"_aioseo_og_article_tags":["a:0:{}"],"catce":["sidebar-widgets4"],"slim_seo":["a:2:{s:5:\"title\";s:49:\"Canine Hip Dysplasia Deep Laser Therapy Solutions\";s:11:\"description\";s:155:\"Resolve deep canine hip dysplasia pain using dual-wavelength Class IV laser therapy targeting hemoglobin and water chromophores without tissue overheating.\";}"],"views":["48"]},"aioseo_notices":[],"aioseo_head":"\n\t\t\n\t\n\t\n\t\n\t\n\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t\n\t\t